Between 26 June and 1 July, 570 young scientists and 24 Nobel Laureates will be assembling at Lake Constance to discuss advances in medical research, absorb fresh inspiration and make contacts. With participants from 80 countries, this year’s Lindau Meeting of Nobel Laureates is more international than ever. Many of the young scientists are coming from developing countries where disease is rife - all the more reason, then, to link the Meeting for the first time with a theme “Global Health”.
The young researchers coming to Lindau will also meet Harald zur Hausen who was awarded the Nobel Prize for Medicine in 2008 for his work in identifying human papilloma virus (HPV) as the cause of cervical cancer. The developing countries account for 80 percent of the women who die each year from cervical cancer. Harald zur Hausen is committed to preventing this type of cancer in these regions: “In pilot projects conducted by the Union for International Cancer Control (UICC), for example in Tanzania, we have initiated HPV vaccination programmes in coordination with the local health authorities.”
Microsoft founder Bill Gates will also attend the opening of the 61st Meeting of Nobel Laureates in Lindau (June 26 at 3.00pm/CET). The Foundation Lindau Nobelprizewinners Meetings at Lake Constance will induct him as member of its Honorary Senate. As part of the opening event, Bill Gates will conduct a podium discussion with the young scientists. Bill & Melinda Gates have been supporting global health projects since 1994. “I believe we have the opportunity to make a new future in which global health is the cornerstone of global prosperity,” said Mr Gates recently in explaining his commitment. The Nobel Laureate Meeting concludes on the Island of Mainau with another podium discussion between five prominent representatives of science and politics, which will also focus on global health.
Breaking the vicious circle of poverty and disease
It is predominantly the populations of the developing countries that are at risk of contracting infectious diseases such as malaria, AIDS and tuberculosis. More than a billion people in these regions are also affected by tropical diseases associated with poverty including river blindness, sleeping sickness and dengue fever, which are predominantly caused by parasites. The occurrence of these diseases in the developed world is negligible, which is why efforts to combat them have long been neglected.
Following the Earth Summit in Rio de Janeiro in 1992, however, the realization slowly began to prevail that sustainable development is only possible provided that we are successful in breaking the vicious circle of poverty and disease in emerging nations. Enabling the inhabitants of these regions to access basic medical care has become a global political priority that was confirmed among the Millennium Development Goals adopted by the United Nations in the year 2000. Under the leadership of the WHO, numerous public-private partnerships have been formed in which governments, NGOs, international authorities, private foundations and pharmaceutical companies have joined forces to specifically combat the tropical diseases fostered by poverty. In 2008 almost 670 million people were treated with drugs to address these once neglected illnesses. The WHO nurtures the hope that by 2020 some of these diseases will have been eliminated entirely.
Concentrated aid brings initial successes
This international cooperation is also having an effect in the fight against AIDS, tuberculosis and malaria: in the past decade, the number of cases of HIV infections and the number of deaths from AIDS have declined by around 20 percent. However, for every two patients that are treated, there are still five new cases of infection. Around 63 percent of all those affected in sub-Saharan Africa still have no access to medication. And the majority of young people in the developing countries still do not know enough about AIDS to protect themselves from it.
One in four deaths among immunodeficient AIDS sufferers is due to tuberculosis, which has become particularly dangerous with the emergence of multi-resistant pathogens in the developing nations. Despite this, by 2008 some 86 percent of all tuberculosis patients were treated successfully.
In 25 countries the number of malaria cases has halved since the year 2000. On the one hand, this is due to the protection afforded by impregnated mosquito nets – 289 million of which have been distributed in sub-Saharan Africa alone – and the use of insect sprays in the home. On the other, it is also attributable to improved diagnosis and drug treatments. There are high hopes of a possible protective vaccination against malaria. An initial vaccine is now undergoing clinical trials. If these prove positive, it should be available by 2015.
Decade of Vaccines
The Gates Foundation has been involved in the development of this vaccine. In the year 2000 the Foundation donated 750 million US dollars to support the establishment of the Global Alliance for Vaccines und Immunization (GAVI). Last Monday (13 June) it announced to donate another one billion US dollars to GAVI. This public-private partnership has set itself the goal of providing every child in the developing countries with access to the vaccinations that their contemporaries in the developed world take for granted. The partnership supports developing countries in their negotiations with vaccine manufacturers and promotes the development of new vaccines against pneumonia, meningitis and diarrheal diseases. A year ago, at the Davos Economic Forum, Bill Gates proclaimed a “Decade of Vaccines” and pledged his Foundation to invest ten billion US dollars by 2020 in researching, developing and distributing vaccines: “They are the most effective and cost-effective health tool ever invented.”
The danger of non-transferable diseases is growing
Harald zur Hausen is one of those taking part in the discussion on the outlook for global health, which rounds off the Nobel Laureate Meeting (Friday, July 1/ 11.00am, Isle of Mainau). He will be joined by Unni Karunakara, President of the international aid organisation "Médecins Sans Frontières", which was awarded the Nobel Peace Prize in 1999; Hans Rosling, Professor of International Health at the Karolinska Institute in Stockholm; James W. Vaupel, Director at the Max Planck Institute for Demographic Research in Rostock, and Georg Schütte, Secretary of State at the German Federal Ministry of Education and Research. These five experts will also consider the increasing threat to global health posed by non-transferable diseases, the bulk of which are avoidable insofar as they are often the product of an unhealthy lifestyle. These include cardiovascular diseases, chronic lung diseases, cancer and diabetes. Already these account for almost two thirds of deaths worldwide. And in a trend in which the developing countries are hardest hit, their frequency is increasing. The WHO is therefore urgently calling for greater efforts to be made in education and prevention. For some countries already grappling with infectious diseases, WHO Director General Margaret Chan recently declared that the spread of these chronic non-transferable diseases constitutes “an impending disaster: a disaster for health, for society, and most of all for national economies.”
“I believe we have the opportunity to make a new future in which global health is the cornerstone of global prosperity.” (Bill Gates, 17 May 2011)
“They are the most effective and cost-effective health tool ever invented.” (Gates Foundation, 2011 Annual Letter from Bill Gates, page 9)
“For some countries, it is no exaggeration to describe the situation as an impending disaster; a disaster for health, for society, and most of all for national economies." (Margaret Chan, 27 April 2011)
Opening Ceremony and Accreditation:
The opening ceremony takes place on June 26, 2011 at 3.00pm /CET at the Inselhalle at Lindau/Germany. It will be streamed live on www.lindau-nobel.org. If you like to register for the opening ceremony/ the meeting please go to: http://www.lindau-nobel.org/Accreditation.AxCMS?ActiveID=1224Programme:
ICTM Conference 2017: Production technology for turbomachine manufacturing of the future
16.11.2016 | Fraunhofer-Institut für Produktionstechnologie IPT
Innovation Day Laser Technology – Laser Additive Manufacturing
01.11.2016 | Laser Zentrum Hannover e.V.
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Earth Sciences
07.12.2016 | Earth Sciences
07.12.2016 | Materials Sciences